Univax

New positions* Bethlehem Steel announced the selection of Alan J. Barsophy as manager of technical services at its Sparrows Point facility.* UNIVAX Biologics, based in Rockville, appointed Samuel W. Shakespeare vice president of sales.* American Office has chosen Bruce Flanagan as an account executive in its Baltimore office. In its Northern Virginia office, Lou Kreiner was named vice president, John Kip and Laura Medvene account executives and Stephen Kramer a sales assistant.* Interior Elements, of Columbia, has added Susan Bennett-Hattan to its staff as director of project management services.

HCIA Inc.BaltimoreTicker .. Yesterday's Symbol .. Cls. .. Chg.HCIA . .. 30 1/4 + 3/8Period ended6/30 .. .. .. .. 2nd qtr. .. Year ago .. .. Chg.Revenue .. .. .. $12,257 ... . $7,741 .. +58.3%Net Income .. ... $1,164 ... ... $278 . +318.7%Primary EPS . .. . $0.15 ... .. $0.05 . +200.0%.. . .. .. .. .. 6 mos. . .. Year ago .. .. Chg.Revenue .. .. . $21,005 . ... $14,525 .. +44.6%Net Income .. .. $1,507 . .. ... $345 . +336.8%Primary EPS . ... $0.21 . .. .. $0.06 . +250.0%Figures in thousands (except per share data.

NEW YORK -- U.S. stocks fell yesterday as continued concern about sales of Microsoft Corp.'s flagship software program Windows 95 pushed technology shares lower.That countered gains in bank shares, which rallied after Chase Manhattan Corp. and Chemical Banking Corp. agreed to merge, topping Citibank as the largest U.S. bank with $297 billion in assets."The big deal is the Chemical-Chase merger," said Phil Schettewi, a portfolio strategist who manages $3 billion for Loomis, Sayles & Co. "The whole financial services industry still has room to consolidate.

Univax Biologics Inc.MA .. .. .. .. .. .. ... .. .. ..Ticker .. .. .. .. .Yesterday's.. .. .. .. .. .. .. .. .. .. ...Symbol .. .. .Cls... .. ...Chg... .. .. .. .. .. .. .. .. .. .. .UNVX .. .. .. 9.. .. .. ...- 3/4Period endedSept. 30 .. .. .. .. ..3rd qtr. .. ..Year ago .. .. .. .. .Chg.Revenue .. .. .. .. .. .$551 .. .. .. .$26 .. .. .. ....+2,019%Net Income .. .. .. .$(4,697) .. .. .$(4,075) .. .. .. .. ...--Primary EPS .. .. .. .$(0.40) .. .. ..$(0.37) .. .. .. .. ...--.. .. .. .. .. .. .. ..9 mos. .. .. .Year ago .. .. .. .. .Chg.

Tom Stagnaro has a company he's sure will make lots o money someday. It's just that 70 percent of the money will be going to someone else.It cost Mr. Stagnaro 70 percent of the stock of his almost 3-year-old company to get $2 million to build its first manufacturing facility. Even that won't buy the factory that will put Univax Biologics Inc. on the map -- just a pilot factory that can make enough of the Rockville company's experimental vaccines to get through clinical trials and Food and Drug Administration review.

Rebound still awaited for biotech stocksThat rebound in biotechnology stocks that some forecasters predicted last week never materialized -- even after positive news from the U.S. Food and Drug Administration for Chiron Corp.Late last week, an FDA advisory panel recommended the agency approve a drug that slows the frequent attacks of certain types of multiple sclerosis. The recommendation wasn't unanimous, but a majority of the panel did find it would be useful to as many as 200,000 patients, according to the company.

Lab technician jobs outpacing supplyLaboratory jobs in the life sciences might grow as much as 3,000 to 4,000 in the next five years in this region, but there may not be qualified people to fill them, according to a report released last week.The Greater Baltimore Committee, the state Department of Economic and Employment Development and the Baltimore Development Corporation wanted to find out what the need for laboratory workers will be in the region in the next decade. It had Migliara/Kaplan Associates, a Towson marketing and research firm, conduct a survey of 63 Baltimore employers, including biotechnology and chemical companies, hospitals and laboratory testing facilities.

Crown posts $5.7 million loss during first quarter of 1993Crown Central Petroleum Corp. Chairman Henry A. Rosenberg Jr. said yesterday that Crown refineries and gas stations lost money in the first three months of 1993.The company said its $5.7 million loss for its first fiscal quarter was because of poor profit margins on refined oil produced by its Texas refineries.The company reported an operating loss of $6.6 million in the same period a year ago.Mr. Rosenberg also announced at the company's annual meeting yesterday the appointment to Crown's board of Robert M. Freeman, chairman of Signet Banking Corp.

Technology councils to brief businessesState officials and regulators will brief business people on technology issues in Maryland Tuesday, Jan. 12, from 7:30 a.m. to 9 a.m. at Howard Community College's Science and Technology Building in Columbia.The briefing is sponsored by several of the region's technology councils. For more information, call (410) 730-4111.Anivax tests vaccine to aid CF patientsUnivax Biologics of Rockville has begun an experiment in its development of a product that would treat a sometimes fatal bacterial infection common in cystic fibrosis patients.

Initial public offerings sure can soak up the money, and they definitely soak up their share of attention. But they're not the only -- not even the biggest -- game in town.For all the fuss, there were more secondary stock offerings than IPOs in the United States last year. Mature companies do secondary offerings -- that is, when a company that's already publicly owned sells more shares -- for different reasons than fledgling companies sell IPOs. And a different breed of investor buys shares in a secondary offering, as an upcoming deal by Baltimore Gas and Electric Co. shows.